Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease.
about
A delicate balance: role of MMP-9 in brain development and pathophysiology of neurodevelopmental disordersRemodelling the extracellular matrix in development and diseaseMatrix metalloproteinases in kidney homeostasis and diseasesMatrix metalloproteinases, atherosclerosis, proteinuria and kidney disease: Linkage-based approachesOcular features in Alport syndrome: pathogenesis and clinical significanceMetalloprotease meprin beta in rat kidney: glomerular localization and differential expression in glomerulonephritis.Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome.Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophagesLaminin α2-mediated focal adhesion kinase activation triggers Alport glomerular pathogenesis.Membrane-type 4 matrix metalloproteinase (MT4-MMP) modulates water homeostasis in mice.A maladaptive role for EP4 receptors in mouse mesangial cells.Mild electrical stimulation and heat shock ameliorates progressive proteinuria and renal inflammation in mouse model of Alport syndromeSearching for a treatment for Alport syndrome using mouse modelsUpregulated expression of integrin α1 in mesangial cells and integrin α3 and vimentin in podocytes of Col4a3-null (Alport) miceRole of the prostaglandin E2/E-prostanoid 2 receptor signalling pathway in TGFβ-induced mice mesangial cell damage.A glimpse of matrix metalloproteinases in diabetic nephropathy.MMP-9 gene deletion mitigates microvascular loss in a model of ischemic acute kidney injury.COL4A4 gene study of a European population: description of new mutations causing autosomal dominant Alport syndrome.Role for macrophage metalloelastase in glomerular basement membrane damage associated with alport syndromeInvestigating mechanisms of chronic kidney disease in mouse modelsMechanisms and consequences of TGF-ß overexpression by podocytes in progressive podocyte disease.Injection of amniotic fluid stem cells delays progression of renal fibrosis.Matrix Metalloproteinase-2 Knockout and Heterozygote Mice Are Protected from Hydronephrosis and Kidney Fibrosis after Unilateral Ureteral Obstruction.Cellular and molecular mechanisms of renal fibrosis.X-Linked Alport Dogs Demonstrate Mesangial Filopodial Invasion of the Capillary Tuft as an Early Event in Glomerular Damage.Glomerular pathology in Alport syndrome: a molecular perspective.Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative.Integrin alpha1beta1 regulates matrix metalloproteinases via P38 mitogen-activated protein kinase in mesangial cells: implications for Alport syndrome.The role of osteopontin in the development of albuminuria.MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathwaysMMPs as therapeutic targets--still a viable option?CD166/ALCAM mediates proinflammatory effects of S100B in delayed type hypersensitivityMetalloproteinases: a Functional Pathway for Myeloid Cells.Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathyMatrix metalloproteinase-9-mediated tissue injury overrides the protective effect of matrix metalloproteinase-2 during colitis.Novel actions of tissue-type plasminogen activator in chronic kidney disease.α1β1 integrin/Rac1-dependent mesangial invasion of glomerular capillaries in Alport syndrome.Glomerular matrix metalloproteinases and their regulators in the pathogenesis of lupus nephritis.Renal tubulointerstitial fibrosis: common but never simple.Biomechanical strain causes maladaptive gene regulation, contributing to Alport glomerular disease.
P2860
Q26797397-35155004-7C4D-4B85-847B-12B6BA9CF781Q26864798-61EB9A2C-27F4-482C-BFB7-B899F12CCFBEQ27004621-7CFF7CBC-E627-4669-8C3D-827B624BA3C0Q27025492-1398B222-E261-498F-8847-45D4FBC29C4DQ28080691-76CA9D5E-219C-4754-A8FD-051324B74F44Q33338489-CA539645-B911-49E6-ACDD-25F1F42EFC03Q33685580-B08E4CC2-1538-4D83-BD17-B8FBB60F8906Q33733803-82B8E1EA-6E14-4981-A0C6-B263B4C519F2Q33734236-C18E0535-54DE-4DB1-A491-8D8BBC491100Q33828362-9D248675-AE64-4833-8403-1DE0B5A75B0DQ34046455-5245FF7D-BF57-4C8E-A904-8EF348FA68E0Q34399470-1E142050-CD79-421A-9EF9-E727FA5427DBQ34453272-87EB8CB2-2E40-4497-A293-27F648037FDBQ34510473-F7D61642-EA84-44E0-9BBA-3A85BD683180Q34706829-F81A21E1-5999-4395-A1D4-953966CA43ADQ34796034-0C23820E-DF22-429A-B0F8-92C2C607AA78Q35086941-40514692-F728-4EA6-BBBD-A256EF9C5BB9Q35144506-FECCF54E-816B-4320-A8FF-F8B1D3C41C0CQ35221882-48518C7B-7EA1-430E-9BAB-77E7E926C9D8Q35422209-EEEFD3CF-708D-4CD2-BBDD-613C5CDA67BFQ35649310-48CE4FB4-EFB4-4776-95F3-D0FA55A726B0Q35853316-41F420D5-9BD5-4EBF-AD3B-9BC7CD93AAE1Q35870277-F17A87B5-988E-430B-80DF-A46892DD4256Q35903772-5C3CCD0B-0322-4366-9C1B-9080713FBEB6Q36222337-81DD7047-CF7C-4D83-93B4-57E307083DCEQ36359599-64ED10F9-DEC2-490B-81B8-7D41D09982EEQ36420940-404FB0E5-20D9-4565-AB14-99BA8065074DQ36482190-6EC663A8-EBDC-44F2-8FC3-6742A504847EQ36662121-D02EC006-BCED-4BA5-ADFE-E14534FD1433Q36901558-9738AA64-CD6B-4734-9DC5-96BD00769010Q36908023-4E7A7978-7CA6-4690-BF9F-1D03C9D718E3Q36948770-65982DC0-06E3-4B2D-8C04-3386EB9CEE87Q36955864-A4AACE71-73A9-4AFE-AF66-E60DE2A6CF7FQ37069135-9ECAAB4A-42CF-4BFF-BA73-5A5040E27D5DQ37100247-253B8E59-3626-46E1-A6F9-73A05F20E092Q37115034-34914D95-5E2B-4155-A4A5-CF9009DD8585Q37218239-C309287B-58AC-4EB4-8E14-13E4FE487D6AQ37353175-ED1871C6-45C5-4106-85FF-99B1403B4DA5Q37368710-CE21A787-A77B-4377-AD08-3AC1582F7A21Q37427367-75E1E521-8F0F-44A4-AD74-B4DA31D4F023
P2860
Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Stage-specific action of matri ...... sive hereditary kidney disease
@nl
Stage-specific action of matri ...... ive hereditary kidney disease.
@ast
Stage-specific action of matri ...... ive hereditary kidney disease.
@en
type
label
Stage-specific action of matri ...... sive hereditary kidney disease
@nl
Stage-specific action of matri ...... ive hereditary kidney disease.
@ast
Stage-specific action of matri ...... ive hereditary kidney disease.
@en
prefLabel
Stage-specific action of matri ...... sive hereditary kidney disease
@nl
Stage-specific action of matri ...... ive hereditary kidney disease.
@ast
Stage-specific action of matri ...... ive hereditary kidney disease.
@en
P2093
P2860
P1433
P1476
Stage-specific action of matri ...... ive hereditary kidney disease.
@en
P2093
Charles F Shield
Dominic Cosgrove
Jean-Philippe Rougier
Michael Zeisberg
Michelle C Werner
Mona Khurana
Raghu Kalluri
Velidi H Rao
P2860
P356
10.1371/JOURNAL.PMED.0030100
P407
P50
P577
2006-03-07T00:00:00Z